CMC Considerations for INDs and NDAs for 505(b)(2) Products
Instructor:
Mukesh Kumar
Product ID: 703393
- Duration: 90 Min
Why Should You Attend:
The Chemistry, Manufacturing and Controls (CMC) section of IND and NDA applications for 505(b)(2) products raises several issues since portions of the information may come from the reference product with additions unique to the said application. Since such products may contain altered versions of previously FDA-approved drugs, sponsors frequently struggle with defining the detail and scope of information to include in their applications.
This webinar will discuss the practical strategies for compiling the CMC sections of 505(b)(2) applications. Key strategic considerations will be discussed using real-life case studies.
Areas Covered in the Webinar:
- The 505(B)(2) regulation and guidance from the FDA
- Strategic considerations for CMC section in a 505(b)(2) application
- Role of DMFs
- Best practices for using cross-reference authorization
- Common errors in CMC section in 505(b)(2) applications and potential solutions
- Examples of successful strategies for developing such products
Who Will Benefit:
- Regulatory Affairs Professionals
- Senior Management Executives (CEO, COO, CFO, etc)
- Drug Discovery and Development Professionals (R&D and CMC)
- Intellectual Property Experts
- Project Managers and Clinical Trial Specialists
- Regulatory Compliance Associates and Managers
- People Investing in FDA-Regulated Product Development Projects
Dr. Mukesh Kumar, is a Washington DC-based consultant in regulatory affairs and quality assurance for manufacturers and developers of FDA-regulated products. He and leads the Regulatory Affairs and Quality Assurance departments at Amarex, a full service pharmaceutical product development company based in Germantown, MD (www.amarexcro.com). His key expertise is in regulatory affairs, clinical trials and multi-national project management for medicinal and diagnostic products. He has been involved in about 100 clinical trials in more than 40 countries, has made several hundred US FDA submissions, and arranged a number of meetings with the US FDA. In addition, he has had made regulatory submission in the EU and India. He has conducted GCP, GLP, GMP and GACP audits in the US and several countries in Europe and Asia.
He has conducted numerous training workshops in FDA compliance related issues. He has authored numerous articles in peer-reviewed journals. He is a well-known expert in global regulatory affairs and has been an invited speaker at several professional and academic organizations worldwide. Dr. Kumar is a PhD in Biochemistry and has worked as a research scientist at the NIH, Baylor College of Medicine, Houston, and premier institutions in India. He is a certified regulatory affair professional by the Regulatory Affairs Professional Society, USA.
More Training By Experts
- How to Withstand an FDA Audit of your Facility
- How to Write SOPs: Tips on Writing the Perfect Document to Impress the FDA
- Dietary Supplements and Nutraceuticals: Compliance with FDA's Current Manufacturing Requirements
- Social Media and Marketing FDA Regulated Products
- Regulatory Perspectives of Clinical Project Management: Meeting FDA Requirements for Clinical Trials
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
